Infinium Pharmachem Limited

Infinium Pharmachem Limited (INFINIUM) is a micro-cap Healthcare company valued at ₹475 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Infinium Pharmachem Limited last traded at ₹305.05, down 2.73% on the day.

Recent developments

On 2026-03-31, the company reported its latest financial results, showing a significant increase in both revenue and net profit compared to the prior year. The company has not paid dividends despite reporting profits, which may indicate a focus on reinvestment rather than shareholder returns.

Financial performance

The company's business has improved, with annual revenue rising 21.6% and annual net profit growing 51.9%. The latest quarter saw revenue jump 45.2% and net profit surge 166.7% compared to the same quarter a year earlier, driven by stronger margins that widened 1.3 percentage points to 6.4%.

Valuation multiples

The stock trades at 39.1 times earnings, a premium to the Healthcare median of 32.0, 3.53 times book value.

Things to watch

The company has not paid dividends despite repeated profits, which could signal a lack of immediate shareholder returns. The stock is currently 1.0% below its 52-week high, indicating a potential pullback from recent peak levels.

Where it stands

Infinium Pharmachem Ltd has delivered strong growth in both revenue and net profit, with the latest quarter showing a sharp rise in earnings. The company's net profit margin has widened, but it has not distributed any dividends to shareholders. The stock is currently trading near its 52-week high, with a market cap of ₹490 crore.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.